Efficacy News and Research

RSS
New study shows increase in certain macrophages may lead to therapeutic targets for Crohn's disease

New study shows increase in certain macrophages may lead to therapeutic targets for Crohn's disease

Study: Self-administration of flu vaccines with microneedle patches may one day be feasible

Study: Self-administration of flu vaccines with microneedle patches may one day be feasible

AbbVie's PEARL-III study meets primary, secondary endpoints in patients with chronic GT1b HCV infection

AbbVie's PEARL-III study meets primary, secondary endpoints in patients with chronic GT1b HCV infection

TherapeuticsMD's fourth quarter 2013 net revenue increases to $2.9 million

TherapeuticsMD's fourth quarter 2013 net revenue increases to $2.9 million

Acucela completes patient enrollment in Phase 2b/3 clinical trial of emixustat hydrochloride

Acucela completes patient enrollment in Phase 2b/3 clinical trial of emixustat hydrochloride

New article explores risks associated with using herbal cannabis for rheumatic conditions

New article explores risks associated with using herbal cannabis for rheumatic conditions

Cell Therapeutics initiates Phase 3 clinical trial to evaluate pacritinib in patients with myelofibrosis

Cell Therapeutics initiates Phase 3 clinical trial to evaluate pacritinib in patients with myelofibrosis

Study explores risks associated with using herbal cannabis for treatment of rheumatic conditions

Study explores risks associated with using herbal cannabis for treatment of rheumatic conditions

Phase III studies show tiotropium delivered via Respimat inhaler proves effective in asthma patients

Phase III studies show tiotropium delivered via Respimat inhaler proves effective in asthma patients

New methodology for rapid detection of antibiotics in blood paves way to drug development, personalized treatment

New methodology for rapid detection of antibiotics in blood paves way to drug development, personalized treatment

Gastric bypass better than gastrectomy for GERD relief

Gastric bypass better than gastrectomy for GERD relief

Xeltis completes enrollment for study of spontaneous tissue growth technology

Xeltis completes enrollment for study of spontaneous tissue growth technology

Celsion reports positive interim data from Phase 2 DIGNITY Trial of ThermoDox in RCWBC

Celsion reports positive interim data from Phase 2 DIGNITY Trial of ThermoDox in RCWBC

Motesanib boosts carboplatin/paclitaxel efficacy in NSCLC

Motesanib boosts carboplatin/paclitaxel efficacy in NSCLC

Adocia reports positive preliminary results for first clinical trial of BioChaperone Combo

Adocia reports positive preliminary results for first clinical trial of BioChaperone Combo

Pacira Pharmaceuticals initiates Phase 3 clinical trial of EXPAREL in femoral nerve block

Pacira Pharmaceuticals initiates Phase 3 clinical trial of EXPAREL in femoral nerve block

Altheus Therapeutics completes dosing of ZA201 in Phase 2 trial of Zoenasa for ulcerative colitis

Altheus Therapeutics completes dosing of ZA201 in Phase 2 trial of Zoenasa for ulcerative colitis

Phase 2 trial results show GPB reduces hepatic encephalopathy episodes in patients with cirrhosis

Phase 2 trial results show GPB reduces hepatic encephalopathy episodes in patients with cirrhosis

Attitudinal beliefs feed negative schizophrenia symptoms

Attitudinal beliefs feed negative schizophrenia symptoms

FDA approves KALYDECO for people with cystic fibrosis

FDA approves KALYDECO for people with cystic fibrosis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.